This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Can Healthy Revenue Growth Aid Axcelis' (ACLS) Q3 Earnings?
by Zacks Equity Research
Axcelis (ACLS) is expected to have recorded year-over-year higher revenues on the back of healthy demand trends.
Ametek (AME) Moves 3.7% Higher: Will This Strength Last?
by Zacks Equity Research
Ametek (AME) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
National Instruments (NATI) Misses Q3 Earnings Estimates
by Zacks Equity Research
National Instruments (NATI) delivered earnings and revenue surprises of -3.64% and 0.29%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cognex Corporation (CGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Cognex Corporation (CGNX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fortive (FTV) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Fortive (FTV) delivered earnings and revenue surprises of 3.95% and 0.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Teradyne (TER) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Teradyne (TER) delivered earnings and revenue surprises of 10.58% and 3.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Company News for Sep 21, 2022
by Zacks Equity Research
Companies in The News Are: F,HUM,CHNG,UNH,CGNX
Cognex (CGNX) Q2 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Cognex (CGNX) second-quarter 2022 results reflect by losses incurred due to damage by fire at Cognex's primary contract manufacturer's factory in Indonesia.
Cognex Corporation (CGNX) Lags Q2 Earnings Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of -2.38% and 0.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Itron (ITRI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Itron (ITRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Cognex Corporation (CGNX) Q2 Earnings Expected to Decline
by Zacks Equity Research
Cognex Corporation (CGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Invesco S&P MidCap Quality ETF (XMHQ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for XMHQ
Cognex Corporation (CGNX) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 7.69% and 2.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Teradyne (TER) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Teradyne (TER) delivered earnings and revenue surprises of 12.64% and 1.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Should Invesco S&P MidCap Quality ETF (XMHQ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for XMHQ
Zacks Industry Outlook Highlights Agilent Technologies, AMETEK, Fortive, and Cognex
by Zacks Equity Research
Agilent Technologies, AMETEK, Fortive, and Cognex Zacks Industry Outlook article.
4 Testing Equipment Stocks to Escape a Challenging Industry
by Shilpa Mete
Coronavirus--led disruptions are hurting the Zacks Electronics - Testing Equipment industry. However, industry participants like A, AME, FTV and CGNX are set to gain from 5G prospects.
Should Vanguard S&P MidCap 400 Growth ETF (IVOG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOG
Cognex Corporation (CGNX) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 30.43% and 8.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cognex Corporation (CGNX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cognex Corporation (CGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Vanguard S&P MidCap 400 Growth ETF (IVOG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOG
Should SPDR S&P 400 Mid Cap Growth ETF (MDYG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDYG
New Strong Sell Stocks for December 29th
by Zacks Equity Research
B, FPI, CGNX, AMED, and FSUGY have been added to the Zacks Rank #5 (Strong Sell) List on December 29, 2021.
New Strong Sell Stocks for December 27th
by Zacks Equity Research
TXRH, VIOT, WBK, AMED and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 27, 2021
New Strong Sell Stocks for December 10th
by Zacks Equity Research
AVAV, HQY, MESA, SWK, and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 10, 2021.